Your browser doesn't support javascript.
loading
Improving the turnaround time of molecular profiling for advanced non-small cell lung cancer: Outcome of a new algorithm integrating multiple approaches.
Treichler, G; Hoeller, S; Rueschoff, J H; Rechsteiner, M; Britschgi, C; Arnold, F; Zoche, M; Hiltbrunner, S; Moch, H; Akhoundova, D; Opitz, I; Curioni-Fontecedro, A.
Afiliação
  • Treichler G; Department of Medical Oncology and Hematology University Hospital Zurich, Switzerland; Comprehensive Cancer Center Zurich, Switzerland; Department of Medical Oncology and Hematology, Cantonal Hospital Winterthur, Switzerland.
  • Hoeller S; Department of Medical Oncology and Hematology University Hospital Zurich, Switzerland; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland; University of Zurich, Switzerland; Comprehensive Cancer Center Zurich, Switzerland.
  • Rueschoff JH; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Rechsteiner M; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Britschgi C; Department of Medical Oncology and Hematology University Hospital Zurich, Switzerland; University of Zurich, Switzerland; Comprehensive Cancer Center Zurich, Switzerland.
  • Arnold F; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Zoche M; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Hiltbrunner S; Department of Medical Oncology and Hematology University Hospital Zurich, Switzerland; Comprehensive Cancer Center Zurich, Switzerland; Faculty of Science and Medicine, University of Fribourg, Switzerland.
  • Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, 8091 Zurich, Switzerland.
  • Akhoundova D; Department of Medical Oncology and Hematology University Hospital Zurich, Switzerland; Comprehensive Cancer Center Zurich, Switzerland; Department of Oncology, University Hospital Bern, Switzerland.
  • Opitz I; University of Zurich, Switzerland; Department of Thoracic Surgery, University Hospital Zurich, Switzerland.
  • Curioni-Fontecedro A; Department of Medical Oncology and Hematology University Hospital Zurich, Switzerland; University of Zurich, Switzerland; Comprehensive Cancer Center Zurich, Switzerland; Faculty of Science and Medicine, University of Fribourg, Switzerland; Department of Oncology, Cantonal Hospital Fribourg, Switzer
Pathol Res Pract ; 248: 154660, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37413876

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Pathol Res Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Pathol Res Pract Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suíça